Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05876429 · ClinicalTrials.gov registry record · NA
Optimizing the Safety of Inter-Hospital Transfer
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 1,658
- Enrollment target
NCT05876429: Completed NA study, sponsored by Brigham and Women's Hospital.
NCT05876429 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 1,658 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (18% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05876429, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,658 participants
- Enrollment target
Study Summary
This proposal aims to design, implement and rigorously evaluate a standardized accept note in a population of patients that have high frequency of IHT, including patients transferred to the general medical (GMS), cardiology and oncology services at a large tertiary care hospital. This study will improve scientific knowledge by quantifying the patient safety impact of an intervention to improve communication of essential clinical information during IHT. If shown effective, the results of this study can be used to improve clinical practice by establishing evidence-based communication guidelines for broad dissemination. We will also establish technical feasibility by successfully implementing this tool within our EHR (Epic, Verona, WI), allowing for feasible adoption and dissemination to other institutions with similar EHR capabilities. Lastly, we will address malpractice risk by investigating a strategic intervention aimed at reducing known contributors to patient harm during IHT, a high-risk transition in care that involves transfer of high-acuity patients between providers, settings and systems of care.
Primary Outcome
Medical errors and adverse events measured as the total number of medical errors per patient
Interventions
- OTHER New Standardized Accept Note
- OTHER Existing Transfer Patient Admission Process
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,658 participants |
| Start Date | 2020-08-17 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
What the finished NCT05876429 record still lists
NCT05876429 is an interventional study that assigns participants to a tested intervention. Its 1,658 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (18% higher).
The record links to 0 conditions, and to 2 interventions - of which New Standardized Accept Note is the first listed.
NCT05876429 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05876429 about?
NCT05876429 is a clinical study titled "Optimizing the Safety of Inter-Hospital Transfer". This proposal aims to design, implement and rigorously evaluate a standardized accept note in a population of patients that have high frequency of IHT, including patients transferred to the general medical (GMS), cardiology and oncology services at a large tertiary care hospital. This study will imp...
What is the current status of trial NCT05876429?
This trial is currently completed. It is a NA study. The enrollment target is 1,658 participants. The study started on 2020-08-17. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT05876429?
The interventions under investigation include: New Standardized Accept Note (OTHER), Existing Transfer Patient Admission Process (OTHER).
Who is sponsoring clinical trial NCT05876429?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05876429's enrollment target sits among peer trials
1,658 62nd of 2000 higher than 1,939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06401330 · 1,656 participants · Phase 3
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
- NCT06034405 · 1,663 participants
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
- NCT06644625 · 1,665 participants
CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
- NCT04510129 · 1,650 participants
A Multicenter Cancer Biospecimen Collection Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI